Free Float 66,11 %
Shares Float 3,19 M
Shares Outstanding 4,82 M
Nirvana Life Sciences Inc.
Share · CA6546521064 (XCNQ)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Nirvana Life Sciences Inc.
No Price
Share Float & Liquidity
Company Profile for Nirvana Life Sciences Inc. Share
Nirvana Life Sciences Inc. engages in the scientific research and development of therapeutic products derived from psychedelics. It also focuses on developing methodologies for extraction and purification of psychoactive compounds; and the improvement of propagation techniques for growing such biomass on a large scale. The company was incorporated in 2020 and is headquartered in Vancouver, Canada.
Company Data
Name Nirvana Life Sciences Inc.
Company Nirvana Life Sciences Inc.
Website
https://nirvanalifesciences.com
Primary Exchange 
CSE LISTED
CSE LISTED
ISIN CA6546521064
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Bruce Clark
Country Canada
Currency CAD
Employees -
Address 905 West Pender Street, V6X 1L3 Vancouver
IPO Date 2022-03-18
Stock Splits
| Date | Split |
|---|---|
| 24.03.2025 | 1:10 |
Ticker Symbols
| Name | Symbol |
|---|---|
| CSE LISTED | NIRV.CN |
More Shares
Investors who hold Nirvana Life Sciences Inc. also have the following shares in their portfolio:
